2m 2m 2m 2m 2m 2m 2m
NRX PHARMA (NRXP)
NASDAQ
$3.44+$0.04 (+1.12%)
Price as of Sep 11, 2026 7:57 PM EDT- $147.2MMarket Cap
- 21.43%1-Year Change
- BiotechnologyIndustry
NRX PHARMA (NRXP)
$3.44+$0.04 (+1.12%)
NRXP | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.40 | ||
Change | $0.00 (0.00%) | ||
Open | $3.44 | ||
High | $3.44 | ||
Low | $3.37 | ||
Previous Close | $3.40 | ||
Volume | 356,231 | ||
30-Day Average Volume | 714,446 | ||
1-Week Change | -2.58% | ||
1-Month Change | 0.00% | ||
1-Year Change | 21.43% | ||
3-Year Change | 29.77% | ||
5-Year Change | -97.18% | ||
Fundamentals | |||
Shares Outstanding | 43.3M | ||
Total Assets | $34.2M | ||
Market Cap | $147.2M | ||
Enterprise Value | $120.9M | ||
Period: QTR TTM FY | |||
Revenue | $1.1M | ||
Net Income | -$16.5M | ||
Free Cash Flow | -$8.9M | ||
EBIT | -$16.5M | ||
EBITDA | -$16.4M | ||
Net Working Capital | -$4.7M | ||
EPS | -$0.44 | ||
Enterprise Value/EBITDA | -7 | ||
Enterprise Value/Revenue | 110 | ||
P/B | -866 | ||
P/E | -8 | ||
PEG | 0 | ||
Price/Free Cash Flow | -17 | ||
Price/Operating Cash Flow | -17 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 04/02/2024 | ||
Earnings & Revenue